Tags

Type your tag names separated by a space and hit enter

Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids.
Emerg Infect Dis. 2020 08; 26(8):1834-1838.EI

Abstract

We prospectively assessed 49 coronavirus disease cases in Guangdong, China, to estimate the frequency and duration of detectable severe acute respiratory syndrome coronavirus 2 RNA in human body fluids. The prolonged persistence of virus RNA in various body fluids may guide the clinical diagnosis and prevention of onward virus transmission.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32383638

Citation

Sun, Jiufeng, et al. "Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids." Emerging Infectious Diseases, vol. 26, no. 8, 2020, pp. 1834-1838.
Sun J, Xiao J, Sun R, et al. Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids. Emerging Infect Dis. 2020;26(8):1834-1838.
Sun, J., Xiao, J., Sun, R., Tang, X., Liang, C., Lin, H., Zeng, L., Hu, J., Yuan, R., Zhou, P., Peng, J., Xiong, Q., Cui, F., Liu, Z., Lu, J., Tian, J., Ma, W., & Ke, C. (2020). Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids. Emerging Infectious Diseases, 26(8), 1834-1838. https://doi.org/10.3201/eid2608.201097
Sun J, et al. Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids. Emerging Infect Dis. 2020;26(8):1834-1838. PubMed PMID: 32383638.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids. AU - Sun,Jiufeng, AU - Xiao,Jianpeng, AU - Sun,Ruilin, AU - Tang,Xi, AU - Liang,Chumin, AU - Lin,Huifang, AU - Zeng,Lilian, AU - Hu,Jianxiong, AU - Yuan,Runyu, AU - Zhou,Pingping, AU - Peng,Jinju, AU - Xiong,Qianlin, AU - Cui,Fengfu, AU - Liu,Zhe, AU - Lu,Jing, AU - Tian,Junzhang, AU - Ma,Wenjun, AU - Ke,Changwen, Y1 - 2020/05/08/ PY - 2020/5/10/pubmed PY - 2020/7/30/medline PY - 2020/5/9/entrez KW - 2019 novel coronavirus disease KW - COVID-19 KW - China KW - Guangdong KW - RNA KW - SARS-CoV-2 KW - coronavirus KW - coronavirus disease KW - persistence KW - respiratory infections KW - severe acute respiratory syndrome coronavirus 2 KW - viruses KW - zoonoses SP - 1834 EP - 1838 JF - Emerging infectious diseases JO - Emerging Infect. Dis. VL - 26 IS - 8 N2 - We prospectively assessed 49 coronavirus disease cases in Guangdong, China, to estimate the frequency and duration of detectable severe acute respiratory syndrome coronavirus 2 RNA in human body fluids. The prolonged persistence of virus RNA in various body fluids may guide the clinical diagnosis and prevention of onward virus transmission. SN - 1080-6059 UR - https://www.unboundmedicine.com/medline/citation/32383638/Prolonged_Persistence_of_SARS_CoV_2_RNA_in_Body_Fluids_ L2 - https://dx.doi.org/10.3201/eid2608.201097 DB - PRIME DP - Unbound Medicine ER -